The relationship between IDH1 mutation isotype and 2-HG inhibition was not investigated in this study, as a previous phase 1 study showed the median values of 2-HG inhibition based on AUC were comparable between the different isotypes in subjects with cholangiocarcinoma [12]. This evidence concerns the gene IDH1 and cholangiocarcinoma.